» Articles » PMID: 15568019

Generation of a Synthetic Lymphoid Tissue-like Organoid in Mice

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2004 Nov 30
PMID 15568019
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Stromal cells play an important role in the formation of the normal organized microarchitecture of secondary lymphoid organs. Here we demonstrate that a tissue-engineered, lymphoid tissue-like organoid, which was constructed by transplantation of stromal cells embedded in biocompatible scaffolds into the renal subcapsular space in mice, had an organized tissue structure similar to secondary lymphoid organs. This organoid contained compartmentalized B-cell and T-cell clusters, high endothelial venule-like vessels, germinal centers and follicular dendritic cell networks. Furthermore, the organoid was transplantable to naive normal or severe combined immunodeficiency (SCID) mice, and antigen-specific, IgG-isotype antibody formation could be induced soon after intravenous administration of the antigen. This simplified system of lymphoid tissue-like organoid construction will facilitate analyses of cell-cell interactions required for development of secondary lymphoid organs and efficient induction of adaptive immune responses, and may have possible applications in the treatment of immune deficiency.

Citing Articles

Deciphering the Human Germinal Center: A Review of Models to Study T-B Cell Interactions.

Fleischmann E, Middelkamp V, van den Broek T Eur J Immunol. 2025; 55(2):e202451460.

PMID: 39931794 PMC: 11811811. DOI: 10.1002/eji.202451460.


Tertiary lymphoid structures in ovarian cancer.

Sun G, Liu Y Front Immunol. 2024; 15:1465516.

PMID: 39569184 PMC: 11576424. DOI: 10.3389/fimmu.2024.1465516.


Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.

Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z Signal Transduct Target Ther. 2024; 9(1):225.

PMID: 39198425 PMC: 11358547. DOI: 10.1038/s41392-024-01947-5.


Tertiary lymphoid structures: new immunotherapy biomarker.

Yang F, Yang J, Wu M, Chen C, Chu X Front Immunol. 2024; 15:1394505.

PMID: 39026662 PMC: 11254617. DOI: 10.3389/fimmu.2024.1394505.


Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.

Osorio J, Knorr D, Weitzenfeld P, Yao N, Baez M, DiLillo M Res Sq. 2024; .

PMID: 38883779 PMC: 11177954. DOI: 10.21203/rs.3.rs-4244833/v1.